2014
DOI: 10.2399/raed.14.46220
|View full text |Cite
|
Sign up to set email alerts
|

The analysis of ankylosing spondylitis patients receiving biological therapies: data from TURKBIO registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
0
0
Order By: Relevance
“…Gender, age, time elapsed after diagnosis (disease duration), comorbidities, and smoking habits of the patients were recorded. The prepandemic planned treatments of the patients were evaluated through their last visit registered in the TURKBIO database [5]. During the study period interviews, the drugs currently used by the patients [NSAID (nonsteroidal anti-inflammatory drug), glucocorticoid (GC), conventional DMARD, conventional synthetic DMARD) and b/ts DMARD] and their doses were recorded.…”
Section: Patientsmentioning
confidence: 99%
“…Gender, age, time elapsed after diagnosis (disease duration), comorbidities, and smoking habits of the patients were recorded. The prepandemic planned treatments of the patients were evaluated through their last visit registered in the TURKBIO database [5]. During the study period interviews, the drugs currently used by the patients [NSAID (nonsteroidal anti-inflammatory drug), glucocorticoid (GC), conventional DMARD, conventional synthetic DMARD) and b/ts DMARD] and their doses were recorded.…”
Section: Patientsmentioning
confidence: 99%